A few months after receiving FDA certification, CarnaLife Holo has been spotlighted by the opinionated industry portal CardiovascularBusiness.com
Cardiovascular Business is a medium from the United States publishing news about business and technology dedicated to cardiovascular medicine. The portal focuses on the business and economic aspects behind the most important clinical, interventional, surgical and information technology, as well as pharmaceuticals and related products that are key to success in cardiovascular practice.
Our CarnaLife Holo mixed reality 3D holographic imaging technology was demonstrated for integration with GE HealthCare’s echocardiograph. The integration enables display and interaction with live 3D holograms of the heart using direct integration with echocardiographers.
Full article available at: https://cardiovascularbusiness.com/topics/cardiac-imaging/glimpse-future-fda-has-cleared-multiple-ar-vr-tools-cardiology
Read more about CarnaLife Holo: https://medapp.pl/en/carnalife-holo/
MedApp – Empowering people for better health.
Source: cardiovascularbusiness.com
